January 11, 2022 Diabetes device makers lead the smaller medtechs Insulin pumps and glucose sensors flew off the shelves, whereas liquid biopsy developers both soared and sank.
July 07, 2021 Smaller medtechs suffer, but not from Covid-19 Emergence from lockdown is the driving force behind many – but not all – of the small and mid-cap share price moves.
